The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Telmisartan-Global Market Insights and Sales Trends 2025
Synopsis
The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Telmisartan market, driven by demand from China, the second largest economy with some signs of stabilising, the Telmisartan market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Telmisartan market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Telmisartan market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Telmisartan sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Telmisartan covered in this report include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc.
The global Telmisartan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Global Telmisartan market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Telmisartan market, Segment by Type:
Injection
Freeze-Dried Powder
Global Telmisartan market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Telmisartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Telmisartan market, driven by demand from China, the second largest economy with some signs of stabilising, the Telmisartan market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Telmisartan market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Telmisartan market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Telmisartan sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Telmisartan covered in this report include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc.
The global Telmisartan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Global Telmisartan market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Telmisartan market, Segment by Type:
Injection
Freeze-Dried Powder
Global Telmisartan market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Telmisartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Telmisartan Market Overview
1.1 Telmisartan Product Overview
1.2 Telmisartan Market Segment by Type
1.2.1 Injection
1.2.2 Freeze-Dried Powder
1.3 Global Telmisartan Market Size by Type
1.3.1 Global Telmisartan Market Size Overview by Type (2018-2029)
1.3.2 Global Telmisartan Historic Market Size Review by Type (2018-2023)
1.3.3 Global Telmisartan Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Telmisartan Sales Breakdown by Type (2018-2023)
1.4.2 Europe Telmisartan Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Telmisartan Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Telmisartan Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Telmisartan Sales Breakdown by Type (2018-2023)
2 Global Telmisartan Market Competition by Company
2.1 Global Top Players by Telmisartan Sales (2018-2023)
2.2 Global Top Players by Telmisartan Revenue (2018-2023)
2.3 Global Top Players by Telmisartan Price (2018-2023)
2.4 Global Top Manufacturers Telmisartan Manufacturing Base Distribution, Sales Area, Product Type
2.5 Telmisartan Market Competitive Situation and Trends
2.5.1 Telmisartan Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Telmisartan Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Telmisartan as of 2022)
2.7 Date of Key Manufacturers Enter into Telmisartan Market
2.8 Key Manufacturers Telmisartan Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Telmisartan Status and Outlook by Region
3.1 Global Telmisartan Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Telmisartan Historic Market Size by Region
3.2.1 Global Telmisartan Sales in Volume by Region (2018-2023)
3.2.2 Global Telmisartan Sales in Value by Region (2018-2023)
3.2.3 Global Telmisartan Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Telmisartan Forecasted Market Size by Region
3.3.1 Global Telmisartan Sales in Volume by Region (2024-2029)
3.3.2 Global Telmisartan Sales in Value by Region (2024-2029)
3.3.3 Global Telmisartan Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Telmisartan by Application
4.1 Telmisartan Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Telmisartan Market Size by Application
4.2.1 Global Telmisartan Market Size Overview by Application (2018-2029)
4.2.2 Global Telmisartan Historic Market Size Review by Application (2018-2023)
4.2.3 Global Telmisartan Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Telmisartan Sales Breakdown by Application (2018-2023)
4.3.2 Europe Telmisartan Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Telmisartan Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Telmisartan Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Telmisartan Sales Breakdown by Application (2018-2023)
5 North America Telmisartan by Country
5.1 North America Telmisartan Historic Market Size by Country
5.1.1 North America Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Telmisartan Sales in Volume by Country (2018-2023)
5.1.3 North America Telmisartan Sales in Value by Country (2018-2023)
5.2 North America Telmisartan Forecasted Market Size by Country
5.2.1 North America Telmisartan Sales in Volume by Country (2024-2029)
5.2.2 North America Telmisartan Sales in Value by Country (2024-2029)
6 Europe Telmisartan by Country
6.1 Europe Telmisartan Historic Market Size by Country
6.1.1 Europe Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Telmisartan Sales in Volume by Country (2018-2023)
6.1.3 Europe Telmisartan Sales in Value by Country (2018-2023)
6.2 Europe Telmisartan Forecasted Market Size by Country
6.2.1 Europe Telmisartan Sales in Volume by Country (2024-2029)
6.2.2 Europe Telmisartan Sales in Value by Country (2024-2029)
7 Asia-Pacific Telmisartan by Region
7.1 Asia-Pacific Telmisartan Historic Market Size by Region
7.1.1 Asia-Pacific Telmisartan Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Telmisartan Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Telmisartan Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Telmisartan Forecasted Market Size by Region
7.2.1 Asia-Pacific Telmisartan Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Telmisartan Sales in Value by Region (2024-2029)
8 Latin America Telmisartan by Country
8.1 Latin America Telmisartan Historic Market Size by Country
8.1.1 Latin America Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Telmisartan Sales in Volume by Country (2018-2023)
8.1.3 Latin America Telmisartan Sales in Value by Country (2018-2023)
8.2 Latin America Telmisartan Forecasted Market Size by Country
8.2.1 Latin America Telmisartan Sales in Volume by Country (2024-2029)
8.2.2 Latin America Telmisartan Sales in Value by Country (2024-2029)
9 Middle East and Africa Telmisartan by Country
9.1 Middle East and Africa Telmisartan Historic Market Size by Country
9.1.1 Middle East and Africa Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Telmisartan Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Telmisartan Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Telmisartan Forecasted Market Size by Country
9.2.1 Middle East and Africa Telmisartan Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Telmisartan Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Telmisartan Products Offered
10.1.5 Pfizer Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Telmisartan Products Offered
10.2.5 Teva Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Telmisartan Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Telmisartan Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Telmisartan Products Offered
10.5.5 Mylan Recent Development
10.6 Reddy's Laboratories (UK)
10.6.1 Reddy's Laboratories (UK) Company Information
10.6.2 Reddy's Laboratories (UK) Introduction and Business Overview
10.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Reddy's Laboratories (UK) Telmisartan Products Offered
10.6.5 Reddy's Laboratories (UK) Recent Development
10.7 Hema Pharmaceuticals Pvt
10.7.1 Hema Pharmaceuticals Pvt Company Information
10.7.2 Hema Pharmaceuticals Pvt Introduction and Business Overview
10.7.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hema Pharmaceuticals Pvt Telmisartan Products Offered
10.7.5 Hema Pharmaceuticals Pvt Recent Development
10.8 Bayer
10.8.1 Bayer Company Information
10.8.2 Bayer Introduction and Business Overview
10.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bayer Telmisartan Products Offered
10.8.5 Bayer Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK Telmisartan Products Offered
10.9.5 GSK Recent Development
10.10 Astellas Pharma Inc
10.10.1 Astellas Pharma Inc Company Information
10.10.2 Astellas Pharma Inc Introduction and Business Overview
10.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Astellas Pharma Inc Telmisartan Products Offered
10.10.5 Astellas Pharma Inc Recent Development
10.11 Nippon Boehringer Ingelheim
10.11.1 Nippon Boehringer Ingelheim Company Information
10.11.2 Nippon Boehringer Ingelheim Introduction and Business Overview
10.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Nippon Boehringer Ingelheim Telmisartan Products Offered
10.11.5 Nippon Boehringer Ingelheim Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Telmisartan Products Offered
10.12.5 Abbott Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Takeda Telmisartan Products Offered
10.13.5 Takeda Recent Development
10.14 Beijing Wansheng Pharmaceutical
10.14.1 Beijing Wansheng Pharmaceutical Company Information
10.14.2 Beijing Wansheng Pharmaceutical Introduction and Business Overview
10.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Beijing Wansheng Pharmaceutical Telmisartan Products Offered
10.14.5 Beijing Wansheng Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Telmisartan Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Telmisartan Industrial Chain Analysis
11.4 Telmisartan Market Dynamics
11.4.1 Telmisartan Industry Trends
11.4.2 Telmisartan Market Drivers
11.4.3 Telmisartan Market Challenges
11.4.4 Telmisartan Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Telmisartan Distributors
12.3 Telmisartan Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
